Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Feb 2028. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or a…
Opportunity overview
- Project name
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)?
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Feb 2028. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or a…
Who is funding Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)?
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) is funded by National Institutes of Health.
When is the deadline to apply for Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)?
The application deadline is 17 Feb 2028 00:00 (UTC).
Where will the Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) project take place?
The project location(s) are: United States.
How can I apply for Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.